H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Census population 112,644. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lansing clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lansing storefront.
Non-Opioid Pain Management Solutions in Lansing, MI for clinics & physicians. Non-opioid pain management w… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Lansing is 39.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Michigan is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for non opioid pain management, not a walk-in clinic.
National Non-Opioid Pain Management Solutions notes (how the product actually works)J8 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Lansing is 12.4% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J8 articles mapped. 9.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 12.4% of adults — 0.4 points above the U.S. 12% figure. Obesity is 39.9%; arthritis is 26.9%. That is place-level BRFSS modeling, not a clinic census and not a Lansing trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Michigan compliance risk.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Ask for the IFU, the lot-traceability packet, and the WPS Government Health Administrators article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Lansing fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Lansing, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lansing is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Lansing — 0.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Lansing. Useful for joint-program math; still needs a diagnosis and privileging.
No Lansing storefront. Joe Bradley is an active practice owner. non opioid pain management stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.